Dawn Lundin has over 25 years of quality assurance and compliance experience from the pharmaceutical industry, academia, and non-profit affiliations. As a subject matter expert in quality across GxPs, Dawn supported regulatory inspections and conducted due diligence visits for many acquisitions and licensing agreements. In 2018, and in attempt to gain more exposure to the patient experience, Dawn left a 20-year career at Merck and accepted a position heading the compliance unit for the Office of Clinical Research at the University of Pennsylvania managing the compliance program for the Perelman School of Medicine. She is now Head of Global Quality Management Systems at  MAPS PBC.

Dawn has a Master of Science in Quality Assurance and Regulatory Affairs from Temple University, a Bachelor of Science in Biology from Delaware Valley University, and a Certificate in Management Engagement from the Wharton School. 

In her spare time, Dawn enjoys time with family, watching her daughter outwit her husband, and snuggle time with her dog Phoebe and rescue cat Gizmo.